Skip to Main Content

Author Details

Ruxandra Draghia-Akli
The Janssen Pharmaceutical Companies of Johnson & Johnson
1993
95
30
PMIDPaper TitleJournal TitlePublished Year
36730407The NIH-led research response to COVID-19.Science2023
37683681The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation.Lancet2023
36814067Digital health technology used in emergency large-scale vaccination campaigns in low- and middle-income countries: a narrative review for improved pandemic preparedness.Expert Rev Vaccines2023
36567021A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships.Antiviral Res2023
36227853An introduction to the Marburg virus vaccine consortium, MARVAC.PLoS Pathog2022
34495876Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines-Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials.Crit Care Med2021
28796411Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.Clin Transl Sci2018
28796445Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.Clin Transl Sci2018
28017443European strategy for vaccine development against infectious diseases.Vaccine2017
28229889Understanding the brain through large, multidisciplinary research initiatives.Lancet Neurol2017
28384507European Union research in support of environment and health: Building scientific evidence base for policy.Environ Int2017
28099066New Vaccines against Epidemic Infectious Diseases.N Engl J Med2017
29749834Enabling personalized medicine in Europe by the European Commission's funding activities.Per Med2017
29214566Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.Adv Exp Med Biol2017
27597459Increased momentum in antimicrobial resistance research.Lancet2016
27642021The need for innovation and implementation research for maternal and newborn health.Lancet2016
26086750Introduction: Gene Therapy and Gene Transfer Projects of the 7th Framework Programme for Research and Technological Development of the European Union (Second Part).Hum Gene Ther Clin Dev2015
26405284Chronic respiratory diseases and lung cancer research: a perspective from the European Union.Eur Respir J2015
26090718Opportunities for vaccine research in Europe.Hum Vaccin Immunother2015
24495209Gene and cell therapy funding opportunities in horizon 2020: an overview for 2014-2015.Hum Gene Ther2014
25457962Better safe than sorry: ethics review in European Union-funded health research.Stem Cells Dev2014
24933558Introduction: gene and cell therapy projects of the seventh framework program.Hum Gene Ther Clin Dev2014
23731282Toward an international initiative for traumatic brain injury research.J Neurotrauma2013
25104151A database on global health research in Africa.Lancet Glob Health2013
22924725Effects of administration of two growth hormone-releasing hormone plasmids to gilts on sow and litter performance for the subsequent three gestations.Am J Vet Res2012
29758818Enabling personalized medicine in Europe: a look at the European Commission's funding activities in the field of personalized medicine research.Per Med2012
23201611European Union support of gene therapy research: a success story.Mol Ther2012
23052295Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.Sci Transl Med2012
23104172Emphasising the European Union's Commitment to Cancer Research: a helicopter view of the Seventh Framework Programme for Research and Technological Development.Oncologist2012
21194033Electroporation of plasmid DNA to swine muscle.Methods Mol Biol2011
21822236IMI moves forward.Nat Biotechnol2011
21957333The selection of experts evaluating health projects for the EU Sixth Framework Program.Z Gesundh Wiss2011
21148501Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge.J Infect Dis2011
21195799European Union vaccine research--an overview.Vaccine2011
19809401A comparison of the growth responses following intramuscular GHRH plasmid administration versus daily growth hormone injections in young pigs.Mol Ther2010
20824656A look inside the framework: EU funding priorities and criteria in the health theme of the co-operation programme.Bioessays2010
20861102Lost without translation. EC's science-friendly future.BMJ2010
20551910Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques.Mol Ther2010
20451642Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.Vaccine2010
20188252Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit.Vaccine2010
20188250Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques.Vaccine2010
20188245Effects of maternal plasmid GHRH treatment on offspring growth.Vaccine2010
19896448Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage.Vaccine2010
19211745Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus.J Virol2009
19683780High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model.Virology2009
19717425DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge.Proc Natl Acad Sci U S A2009
19149896Gene therapy by electroporation for the treatment of chronic renal failure in companion animals.BMC Biotechnol2009
19223870Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments.Mol Ther2009
18082294Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques.Vaccine2008
18721073Effects of plasmid growth hormone-releasing hormone treatment during heat stress.DNA Cell Biol2008
  • 1 - 50 of 95

Recommended Authors

University of British Columbiagrid.17091.3e
Career Start Year 2008
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 0
McGill University
Career Start Year 2001
Number of shared co-authors 0
Bowdoin College
Career Start Year 1997
Number of shared co-authors 0
Moffitt Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Universite de Strasbourg, CNRS, INSERM, Institut de La Clinique de La Souris
Career Start Year 1995
Number of shared co-authors 1
College of Medicine, University of Florida
Career Start Year 1994
Number of shared co-authors 0
College of Medicine, University of Florida
Career Start Year 1994
Number of shared co-authors 0
University of California berkeley
Career Start Year 1994
Number of shared co-authors 0
McLean Hospital and Program in Neuroscience, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 1
Institute of Human Genetics, University of Bonn and Department of Genomics
Career Start Year 1991
Number of shared co-authors 0
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Career Start Year 1990
Number of shared co-authors 0
Medical College of Wisconsin
Career Start Year 1990
Number of shared co-authors 0
University of Cape Town
Career Start Year 1988
Number of shared co-authors 0
Translational Research Institute for Space Health
Career Start Year 1988
Number of shared co-authors 0
University of Minnesota
Career Start Year 1986
Number of shared co-authors 0
University of Southern California Keck School of Medicine
Career Start Year 1985
Number of shared co-authors 0
University of California davis
Career Start Year 1985
Number of shared co-authors 7
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
University of California
Career Start Year 1982
Number of shared co-authors 0
Vita-Salute San Raffaele University
Career Start Year 1980
Number of shared co-authors 1
Synthego Corporation
Career Start Year 1978
Number of shared co-authors 0
National Centre for Cell Science, SP Pune University Campus
Career Start Year 1977
Number of shared co-authors 0
Brown University
Career Start Year 1976
Number of shared co-authors 1
QIMR Berghofer Medical Research Institute
Career Start Year 1976
Number of shared co-authors 0
Stellenbosch Institute of Advanced Study, University of Toronto
Career Start Year 1976
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 2
Exercise Medicine Research Institute, Edith Cowan University
Career Start Year 1973
Number of shared co-authors 0
Enterin Research Institute Inc.
Career Start Year 1969
Number of shared co-authors 0
and School of Public Health, University of Michigan ann arbor
Career Start Year 1965
Number of shared co-authors 0

Collaborators

Wistar Institute
Co-authored papers 12
Co-authored papers 4
Children's Hospital of Eastern Ontario Research Institute
Co-authored papers 3
The University of Notre Dame Australia
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
INSERM
Co-authored papers 3
St. George's University Medical School
Co-authored papers 3
Children's Hospital of Eastern Ontario
Co-authored papers 3
Novartis Gene Therapies
Co-authored papers 3
King Edward Memorial Hospital
Co-authored papers 3
Drexel University College of Medicine
Co-authored papers 3
Co-authored papers 2
Texas Biomedical Research Institute
Co-authored papers 2
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
McGill University. Montreal
Co-authored papers 2
Keio University School of Medicine
Co-authored papers 2
The Foundation for the National Institutes of Health
Co-authored papers 2
University of Michigan ann arbor
Co-authored papers 2
Institut National de la Sante et de la Recherche Medicale
Co-authored papers 2
Foundation for the National Institutes of Health
Co-authored papers 2
National Institute of Neurological Disorders and Stroke
Co-authored papers 2
National Center for Rare Diseases, Istituto Superiore di Sanita
Co-authored papers 2
King Edward Memorial Hospital for Women Perth
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III (ISCIII)
Co-authored papers 1
Institute of Virology, Philipps University Marburg
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1